
1. Trends Parasitol. 2014 Nov;30(11):511-3. doi: 10.1016/j.pt.2014.09.005. Epub 2014
Oct 13.

Gene-therapy for malaria prevention.

Rodrigues MM(1), Soares IS(2).

Author information: 
(1)Centro de Terapia Celular e Molecular (CTCMol), Universidade Federal de São
Paulo, São Paulo, SP, Brazil; Departamento de Microbiologia, Imunologia e
Parasitologia, Universidade Federal de São Paulo-Escola Paulista de Medicina, São
Paulo, SP, Brazil. Electronic address: mrodrigues@unifesp.br.
(2)Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências
Farmacêuticas, Universidade de São Paulo, São Paulo, SP, Brazil.

The limited number of tools for malaria prevention and the inability to eradicate
the disease have required large investments in vaccine development, as vaccines
have been the only foreseeable type of immunoprophylaxis against malaria. An
alternative strategy named vectored immunoprophylaxis (VIP) now would allow
genetically transduced host cells to assemble and secrete antibodies that
neutralize the infectivity of the malaria parasite and prevent disease.

Copyright © 2014 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.pt.2014.09.005 
PMID: 25444237  [Indexed for MEDLINE]

